Guidance for Y-mAbs Therapeutics (YMAB)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | N/A | N/A | $87.00M – 95.00M | $91.66M | = Maintained | Details |
| 2024 | N/A | N/A | $87.00M – 95.00M | $95.18M | = Maintained | Details |
| 2024 | N/A | N/A | $95.00M – 100.00M | $96.87M | = Maintained | Details |
